X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electric communication technique (18) 18
electricity (18) 18
humans (14) 14
basic electronic circuitry (11) 11
broadcast communication (11) 11
selecting resonant circuits (11) 11
tuning resonant circuits (11) 11
physics (10) 10
transmission (9) 9
animals (6) 6
deaf-aid sets (6) 6
female (6) 6
loudspeakers, microphones, gramophone pick-ups or likeacoustic electromechanical transducers (6) 6
performing operations (6) 6
public address systems (6) 6
transporting (6) 6
vehicles in general (6) 6
vehicles, vehicle fittings, or vehicle parts, not otherwiseprovided for (6) 6
calculating (5) 5
computing (5) 5
counting (5) 5
electric digital data processing (5) 5
information storage (5) 5
information storage based on relative movement between recordcarrier and transducer (5) 5
male (5) 5
oncology (5) 5
analysis (4) 4
neurosciences (4) 4
perception - physiology (4) 4
abridged index medicus (3) 3
aerosols (3) 3
afferent pathways - physiology (3) 3
aged (3) 3
atmosphere (3) 3
atmospheric models (3) 3
biochemistry & molecular biology (3) 3
cell line, tumor (3) 3
chemistry (3) 3
cisplatin (3) 3
climate (3) 3
climate models (3) 3
expression (3) 3
mechanoreceptive afferents (3) 3
meteorology & atmospheric sciences (3) 3
middle aged (3) 3
neural coding (3) 3
neurophysiology (3) 3
peripheral vascular disease (3) 3
psychophysics (3) 3
radiative forcing (3) 3
receptive-fields (3) 3
responses (3) 3
somatosensory (3) 3
activation (2) 2
adhesion (2) 2
adult (2) 2
apoptosis (2) 2
area 3b (2) 2
blotting, western (2) 2
cancer (2) 2
cancer therapies (2) 2
care and treatment (2) 2
carrier proteins - metabolism (2) 2
cell adhesion (2) 2
clinical neurology (2) 2
clouds (2) 2
computer simulation (2) 2
diabetes mellitus (2) 2
drug dosages (2) 2
environmental aspects (2) 2
fak (2) 2
fda approval (2) 2
fibronectin (2) 2
further section (2) 2
glabrous skin (2) 2
gyroscopic instruments (2) 2
hematology (2) 2
immunoblotting (2) 2
lung cancer (2) 2
macaca mulatta (2) 2
macaque (2) 2
measuring (2) 2
measuring distances, levels or bearings (2) 2
mechanoreceptor (2) 2
mechanoreceptors - physiology (2) 2
medicine, general & internal (2) 2
models, neurological (2) 2
monkey (2) 2
navigation (2) 2
neural conduction - physiology (2) 2
neural mechanisms (2) 2
neurons - physiology (2) 2
oxidation-reduction (2) 2
p130 (2) 2
parameter uncertainty (2) 2
perception (2) 2
peripheral nerve (2) 2
phosphatidylinositol 3-kinase (2) 2
phosphorylation (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Angelaki, ISSN 0969-725X, 12/2000, Volume 5, Issue 3, pp. 31 - 38
Journal Article
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 12/2006, Volume 26, Issue 12, pp. 2666 - 2672
Journal Article
The Neuroscientist (Baltimore, Md.), ISSN 1089-4098, 2016, Volume 8, Issue 2, pp. 111 - 121
There have been three main ideas about the basic law of psychophysics. In 1860, Fechner used Weber’s law to infer that the subjective sense of intensity is... 
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 7, pp. 629 - 640
Journal Article
Journal Article
Pediatric emergency care, ISSN 0749-5161, 03/2016, Volume 32, Issue 3, pp. 197 - 199
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article